Overview

Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Study

Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether repeated ivermectin mass drug administrations to Burkinabé villagers, performed in three week intervals over the rainy-season, is well-tolerated and safe, and also effective in reducing local malaria transmission and thus clinical malaria episodes in treated village children.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Colorado State University
Collaborators:
Centre Muraz
Institut de Recherche en Sciences de la Sante, Burkina Faso
Ministère de la Santé du Burkina Faso
Treatments:
Albendazole
Ivermectin